Please use this identifier to cite or link to this item:
Title: 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative
Author: Dejaco, Christian
Singh, Yogesh P.
Perel, Pablo
Hutchings, Andrew
Camellino, Dario
Mackie, Sarah L.
Abril, Andy
Bachta, Artur
Balint, Peter
Barraclough, Kevin
Bianconi, Lina
Buttgereit, Frank
Carsons, Steven
Ching, Daniel
Cid Xutglà, M. Cinta
Cimmino, Marco A.
Diamantopoulos, Andreas P.
Docken, William
Duftner, Christina
Fashanu, Billy
Gilbert, Kate
Hildreth, Pamela
Hollywood, Jane
Jayne, David
Lima, Manuella
Maharaj, Ajesh
Mallen, Christian
Martinez-Taboada, Victor
Maz, Mehrdad
Merry, Steven
Miller, Jean
Mori, Shunsuke
Neill, Lorna
Nordborg, Elisabeth
Nott, Jenifer
Padbury, Hannah
Pease, Colin
Salvarani, Carlo
Schirmer, Michael
Schmidt, Wolfgang
Spiera, Robert
Tronnier, David
Wagner, Alexandre
Whitlock, Madeleine
Matteson, Eric L
Dasgupta, Bhaskar
Keywords: Reumatologia
Issue Date: 1-Oct-2015
Publisher: BMJ Publishing Group
Abstract: Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international recommendations for PMR treatment are not currently available. In this paper, we report the 2015 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) recommendations for the management of PMR. We used the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology as a framework for the project. Accordingly, the direction and strength of the recommendations are based on the quality of evidence, the balance between desirable and undesirable effects, patients'and clinicians'values and preferences, and resource use. Eight overarching principles and nine specific recommendations were developed covering several aspects of PMR, including basic and follow-up investigations of patients under treatment, risk factor assessment, medical access for patients and specialist referral, treatment strategies such as initial glucocorticoid (GC) doses and subsequent tapering regimens, use of intramuscular GCs and disease modifying anti-rheumatic drugs (DMARDs), as well as the roles of non-steroidal anti-rheumatic drugs and non-pharmacological interventions. These recommendations will inform primary, secondary and tertiary care physicians about an international consensus on the management of PMR. These recommendations should serve to inform clinicians about best practices in the care of patients with PMR.
Note: Reproducció del document publicat a:
It is part of: Annals of the Rheumatic Diseases, 2015, vol. 74, num. 10, p. 1799-1807
Related resource:
ISSN: 0003-4967
Appears in Collections:Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
665016.pdf767.7 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.